XML 49 R35.htm IDEA: XBRL DOCUMENT
v3.20.4

Stockholders' Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Stock Option Activities of Long-Term Incentive and Option Plans | The following information relates to our long-term incentive plans:
|  | December 31, 2020 |
|  | 2016 Plan |  |  | 2008 Plan |
Maximum number of securities for issuance |  |  | 2,750,000 |  |  |  |  |
Number of awards available to be granted (1) |  |  | 1,016,951 |  |  |  |  |
Number of unvested restricted stock/performance-based restricted stock/restricted stock units outstanding |  |  | 1,169,527 |  |  |  | — |
Number of options outstanding |  |  | — |  |  |  | 122,000 |
Number of options exercisable |  |  | — |  |  |  | 122,000 |
.
(1) | Includes 2008 Plan shares canceled, forfeited, expired unexercised, which became available for reissuance under the 2016 Plan after the effective date of the 2016 Plan.
|  | 2020 |
|  | Shares |  |  | Weighted-Average Exercise Price |
Outstanding at beginning of year |  |  | 124,000 |  |  | $ | 33.86 |
Granted |  |  | — |  |  | $ | — |
Exercised |  |  | — |  |  | $ | — |
Forfeited or expired |  |  | (2,000 | ) |  | $ | 34.50 |
Outstanding at end of year |  |  | 122,000 |  |  | $ | 33.85 |
Exercisable at end of year |  |  | 122,000 |  |  | $ | 33.85 |
|  | 2020 |  |  | 2019 |  |  | 2018 |
Stock-based compensation expense - Cost of sales |  | $ | 106,000 |  |  | $ | 122,000 |  |  | $ | 141,000 |
Stock-based compensation expense - SG&A |  | $ | 42,000 |  |  | $ | 50,000 |  |  | $ | 71,000 |
Income tax benefit |  | $ | (36,000 | ) |  | $ | (42,000 | ) |  | $ | (54,000 | )
Total intrinsic value of options exercised during the year |  | $ | — |  |  | $ | — |  |  | $ | — |
Total fair value of options vested during the year |  | $ | 180,000 |  |  | $ | 169,000 |  |  | $ | 169,000 |
Total intrinsic value of options outstanding at end of year |  | $ | — |  |  | $ | — |  |  | $ | — |
Total intrinsic value of options exercisable at end of year |  | $ | — |  |  | $ | — |  |  | $ | — |
Total weighted-average remaining vesting period in years |  |  | — |  |  |  | 0.49 |  |  |  | 1.05 |
Total weighted-average remaining contractual life period in years (options outstanding) |  | 2.64 |  |  |  | 3.61 |  |  |  | 4.61 |
Total weighted-average remaining contractual life period in years (options exercisable) |  | 2.64 |  |  |  | 3.47 |  |  |  | 4.31 |
Summary of Restricted Stock Activity | A summary of restricted stock activity during 2020 is presented below:
|  | Restricted Stock |  |  | Performance-Based Restricted Stock |  |  | Restricted Stock Units |
|  | Shares |  |  | Weighted- Average Grant Date Fair Value |  |  | Shares |  |  | Weighted- Average Grant Date Fair Value |  |  | Shares |  |  | Weighted- Average Grant Date Fair Value |
Unvested outstanding beginning of year |  |  | 618,072 |  |  | $ | 5.42 |  |  |  | 221,439 |  |  | $ | 7.26 |  |  |  | 86,340 |  |  | $ | 6.51 |
Granted |  |  | 31,138 |  |  | $ | 2.81 |  |  |  | 306,257 |  |  | $ | 3.20 |  |  |  | 231,816 |  |  | $ | 1.10 |
Vested |  |  | (283,418 | ) |  | $ | 4.90 |  |  |  | — |  |  | $ | — |  |  |  | (18,996 | ) |  | $ | 9.87 |
Cancelled or forfeited |  |  | (23,121 | ) |  | $ | 7.97 |  |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Unvested outstanding end of year |  |  | 342,671 |  |  | $ | 4.53 |  |  |  | 527,696 |  |  | $ | 4.90 |  |  |  | 299,160 |  |  | $ | 2.11 |
|  | Restricted Stock |
|  | 2020 |  |  | 2019 |  |  | 2018 |
Shares of restricted stock granted |  |  | 31,138 |  |  |  | 285,956 |  |  |  | 369,350 |
Total fair value of restricted stock granted |  | $ | 87,000 |  |  | $ | 1,223,000 |  |  | $ | 2,019,000 |
Weighted-average fair value per restricted stock granted during year |  | $ | 2.81 |  |  | $ | 4.28 |  |  | $ | 5.47 |
Stock-based compensation expense - Cost of sales |  | $ | 62,000 |  |  | $ | 255,000 |  |  | $ | 385,000 |
Stock-based compensation expense - SG&A (1) |  | $ | 1,078,000 |  |  | $ | 1,263,000 |  |  | $ | 7,574,000 |
Income tax benefit |  | $ | (279,000 | ) |  | $ | (374,000 | ) |  | $ | (398,000 | )
Total weighted-average remaining vesting period in years |  | 1.61 |  |  | 2.18 |  |  |  | 1.78 |
Total fair value of restricted stock vested during the year |  | $ | 1,389,000 |  |  | $ | 3,371,000 |  |  | $ | 7,355,000 |
|  | Performance-Based Restricted Stock |  |  | Performance-Based Restricted Stock |  |  |  |
|  | 2020 (2) |  |  | 2019 (2) |  |  |  |
Shares of PBRS granted |  |  | 306,257 |  |  |  | 221,439 |  |  |  |
Total fair value of PBRS granted |  | $ | 980,000 |  |  | $ | 1,608,000 |  |  |  |
Weighted-average fair value per PBRS granted during year |  | $ | 3.20 |  |  | $ | 7.26 |  |  |  |
Stock-based compensation expense - Cost of sales |  | $ | — |  |  | $ | 53,000 |  |  |  |
Stock-based compensation expense - SG&A |  | $ | 218,000 |  |  | $ | 290,000 |  |  |  |
Income tax benefit |  | $ | (53,000 | ) |  | $ | (84,000 | ) |  |  |
Total weighted-average remaining vesting period in years |  |  | 1.57 |  |  |  | 1.85 |  |  |  |
Total fair value of PBRS vested during the year |  | $ | — |  |  | $ | — |  |  |  |
|  | Restricted Stock Units |
|  | 2020 |  |  | 2019 |  |  | 2018 |
Shares of RSU granted |  |  | 231,816 |  |  |  | 31,833 |  |  |  | 35,511 |
Total fair value of RSU granted |  | $ | 255,000 |  |  | $ | 187,000 |  |  | $ | 187,000 |
Weighted-average fair value per RSU granted during year |  | $ | 1.10 |  |  | $ | 5.89 |  |  | $ | 5.28 |
Stock-based compensation expense - SG&A |  | $ | 255,000 |  |  | $ | 187,000 |  |  | $ | 187,000 |
Income tax benefit |  | $ | (63,000 | ) |  | $ | (46,000 | ) |  | $ | (34,000 | )
Total weighted-average remaining vesting period in years |  |  | 0.48 |  |  |  | 1.57 |  |  |  | 1.75 |
Total fair value of RSU vested during the year |  | $ | 187,000 |  |  | $ | 187,000 |  |  | $ | 125,000 |
(1) | As it relates to 2018, s ee Note 14-Related Party Transactions.
(2) | The PBRS restricted stock grants are tied to our free cash flow, fixed costs per ton of ammonia measured annually over a three-year period and modified based on our ranking relative to total stockholder return (share price appreciation plus dividends reinvested) (“TSR”) versus the companies in our 2020 and 2019 peer group (“Peer Group”) for the year of grant over a three-year measurement period. The actual number of shares that will vest at the end of the third year will be based on our performance against the metrics set in the awards but are subject to reduction to a minimum (or even zero) for recording less than the targeted performance. The threshold performance for free cash flow is 70% and for fixed costs per ton of ammonia is 60% of the targeted improvement with a maximum for each of 120% of target. The TSR modifier will adjust the overall actual performance up or down by as much as 25% based on our TSR versus the Peer Group average TSR. We estimate the fair value of each PBRS on the date of grant using a Monte Carlo simulation.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration